|
|
Volumn 123, Issue 3, 2008, Pages 346-347
|
|
Peripartum cardiomyopathy: A new successful setting for levosimendan
|
|
Author keywords
Heart failure; Levosimendan; Peripartum cardiomyopathy; Treatment
|
|
Indexed keywords
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
LEVOSIMENDAN;
SPIRONOLACTONE;
ACUTE HEART FAILURE;
ADULT;
ARTICLE;
CARDIOMYOPATHY;
CASE REPORT;
CONTINUOUS INFUSION;
DRUG EFFICACY;
DRUG RESPONSE;
DRUG SAFETY;
FEMALE;
HEART LEFT VENTRICLE MASS;
HUMAN;
LOADING DRUG DOSE;
PERIPARTUM CARDIOMYOPATHY;
PRIORITY JOURNAL;
SYSTOLIC BLOOD PRESSURE;
SYSTOLIC DYSFUNCTION;
TRANSTHORACIC ECHOCARDIOGRAPHY;
ADULT;
CARDIOTONIC AGENTS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
FOLLOW-UP STUDIES;
HEART FAILURE;
HUMANS;
HYDRAZONES;
INFUSIONS, INTRAVENOUS;
POSTPARTUM PERIOD;
PREGNANCY;
PYRIDAZINES;
RISK ASSESSMENT;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
VENTRICULAR DYSFUNCTION, LEFT;
|
|
EID: 37349081208
PISSN: 01675273
EISSN: None
Source Type: Journal
DOI: 10.1016/j.ijcard.2006.11.171 Document Type: Article |
|
Times cited : (23)
|
|
References (5)
|
